- Management of primary and secondary tumours of the central nervous system, eyes and pediatric malignancies
- Methods of optimizing radiation treatment for malignancies of the brain by conformal radiation therapy and/or sensitizing agents
- Determining the value of stereotactically directed radiation therapy for primary tumours of the eye
- Investigating predictive values of MRI spectroscopy/PET changes relative to recurrence patterns of malignant glioma in brain
Normand J Laperriere
Childs Nerv Syst. 2017 Mar 01;:
Pediatr Blood Cancer. 2017 Feb 16;:
Ann Oncol. 2014 Sep 01;25(suppl_4):iv138-iv139
SU-F-T-116: Predicting IQ and the Risk of Hearing Loss Following Proton Versus Photon Radiotherapy for Pediatric Brain Tumor Patients.
Med Phys. 2016 Jun;43(6):3488
A population-based study of glioblastoma multiforme (GBM) in the new stupp paradigm: Have we improved outcome?
J Clin Oncol. 2011 May 20;29(15_suppl):2012
J Clin Oncol. 2011 May 20;29(15_suppl):2063
Endocrine complications in children treated for medulloblastoma or ependymoma using radiation therapy. Outcomes in the CT-planning era.
J Clin Oncol. 2009 May 20;27(15_suppl):10064
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: Radiation therapy oncology group trial 9402.
J Clin Oncol. 2009 May 20;27(15_suppl):e20519
Med Dosim. 2016 Winter;41(4):271-276
Predicting IQ and the Risk of Hearing Loss Following Proton Versus Photon Radiation Therapy for Pediatric Brain Tumor Patients.
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E684-E685
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
Staff Radiation Oncologist, Princess Margaret Cancer Centre
Associate Director, Gerry and Nancy Pencer Brain Tumour Centre, Princess Margaret Cancer Centre